Washington, D.C. antitrust/competition partner Julia York participated in the American Bar Association’s 2022 Antitrust in Health Care Conference on June 3. During the session “Pharma Conduct Trends: Biosimilars, Generics, Pay-For-Delay,” Ms. York discussed the latest trends in federal enforcement efforts involving reverse payment deals, including a recent FTC win and the potential for rulemaking, the DOJ’s generics price-fixing cases and recent developments in civil litigation involving biosimilars.
Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates